STOCK TITAN

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2020 Financial Results

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings
Rhea-AI Summary

PTC Therapeutics, Inc. (NASDAQ: PTCT) will host a webcast conference call on October 29, 2020, at 4:30 p.m. (ET), to report third quarter 2020 financial results and update its business outlook. Investors can access the call by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) with the passcode 7096445. A live webcast will also be available on the company’s website and a replay will be archived for 30 days. PTC focuses on developing medicines for rare disorders and aims to provide access to innovative treatments.

Positive
  • Company's webcast will provide insights into Q3 2020 financial performance.
  • Focus on rare disorder treatments aligns with unmet patient needs.
Negative
  • None.

SOUTH PLAINFIELD, N.J., Oct. 15, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced that the Company will host a webcast conference call to report its third quarter 2020 financial results and provide an update on the company's business and outlook on Thursday, October 29, 2020 at 4:30 p.m. (ET) after the closing of the market.

The call can be accessed by dialing (877) 303-9216 (domestic) or (973) 935-8152 (international) five minutes prior to the start of the call and providing the passcode 7096445. A live, listen-only webcast of the conference call can be accessed on the investor relations section of the PTC website at www.ptcbio.com. A webcast replay of the call will be available approximately two hours after completion of the call and will be archived on the company's website for 30 days following the call.

About PTC Therapeutics, Inc.

PTC is a science-driven, global biopharmaceutical company focused on the discovery, development and commercialization of clinically differentiated medicines that provide benefits to patients with rare disorders. PTC's ability to globally commercialize products is the foundation that drives investment in a robust and diversified pipeline of transformative medicines and our mission to provide access to best-in-class treatments for patients who have an unmet medical need.

FOR MORE INFORMATION PLEASE CONTACT:

Media:

Investors:

Jane Baj

Lisa Hayes

+1 (908) 912-9167

+1 (732) 354-8687

jbaj@ptcbio.com

lhayes@ptcbio.com  

 

Cision View original content:http://www.prnewswire.com/news-releases/ptc-therapeutics-to-host-conference-call-to-discuss-third-quarter-2020-financial-results-301147176.html

SOURCE PTC Therapeutics, Inc.

FAQ

When will PTC Therapeutics report its Q3 2020 financial results?

PTC Therapeutics will report its Q3 2020 financial results on October 29, 2020.

How can I access the PTC Therapeutics conference call?

The conference call can be accessed by dialing (877) 303-9216 for domestic calls and (973) 935-8152 for international calls.

What is the purpose of the PTC Therapeutics conference call on October 29, 2020?

The conference call will discuss third quarter 2020 financial results and provide a business update.

Will there be a replay of the PTC Therapeutics conference call?

Yes, a replay of the conference call will be available approximately two hours after the call and will be archived for 30 days.

PTC Therapeutics, Inc.

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Stock Data

3.39B
77.13M
2.34%
105.79%
6.06%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
WARREN